For Industry/Pharma with ALS Pipeline

The HEALEY ALS Platform Trial will keep adding treatment arms. To learn more, pharma companies with a therapy for ALS can contact us via email.

Download therapy application formContact for researchers & industryContact for patients

Pioneering Breakthroughs Together

Healey Logo

Collaboration is the key to our success. We believe sharing knowledge and expertise are essential to rapidly bringing innovative therapies to patients. That’s why we are partnering with leading industry and academic institutions to launch the first platform trial for ALS and share information with our peers to accelerate therapeutic innovation. To join us, email HealeyAMGCenterforALS@mgh.harvard.edu.

Industry Partnerships

Academic Partnerships

Our commitment to advancing treatment and therapies for individuals with ALS encourages us to the constant pursuit of new research partnerships and collaborations. We look forward to sharing our progress as we work towards our goal: to find a cure for ALS. We can do this together!

Investigator Resources

Apply to Join the Platform Trial
Master Protocol
Appendices and Policies
Publications

Platform Trial Request for Proposals

Applications are now open for investigational products to be included in the HEALEY ALS Platform Trial.

Download RFP

Support the Sean M. Healey and AMG Center for ALS

Your support helps us provide excellent patient care today, and expands the boundaries of what will be possible in the future.

Support us

Platform Trial Informational Industry Webinar

Learn about the trial's operational structure and how your company can partner with the Healey Center to test new investigational products for ALS.

Watch now